Tuesday, 17 Sep 2019

You are here

The RheumNow Week in Review – 28 July 2017

Dr. Jack Cush reviews the news and articles from the past week on RheumNow.com:

  1. Biologics makes for ~90% of cost of RA care - infusions cost/Yr RTX $36,663; TCZ $36,821, INFLX $4,973; ABA $46,532 https://t.co/HJNaVh4A5m
  2. EU/EMA follows FDA decision to approve Orencia (abatacept) for use in active psoriatic arthritis as mono or combo Rx https://t.co/RkxRsGKahQ
  3. NIH/NIAID phase I & II trial of MV-CHIKV, a recombinant, live-attenuated measles vax expressing chikungunya proteins https://t.co/UjAQelwz8r
  4. Retrospective study 1171 ANCA+ vasculitis shows 16% w/ inflamm ocular disease – Half with eye pain, 16% visuall loss: Scleritis 22% episcleritis 21%, Uveitis 9%  https://t.co/qqrXgaLkBf
  5. RCT shows ustekinumab or guselkumab does NOT significantly reduce the signs and symptoms of RA. https://t.co/14N8ZsKbZ3
  6. Discrepancy between ultrasound and DECT quantification of urate tophi in gout joints; lower sensitivity with DECT https://t.co/RL5Vkq6GSz
  7. Samsung Bioepis launches U.S. sales of Remicade biosmiliar- Renflexis https://t.co/emo6Te0yyW
  8. Biosimilar Pricing Wars Have Begun  
  9. Baricitinib Derailed by FDA Review
  10. Benlysta FDA Approved for Sub-Q Use in Lupus 
  11. Increased Pulmonary Embolism Risk in Lupus Patients  

 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – The End of Arthritis (9.13.19)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – Do’s and Don’ts in Spondylitis (9.5.19)

Dr. Jack Cush reviews the news and important research published in the last two weeks on RheumNow.com.

Influenza Vaccination Update

FDA's Vaccines and Related Biological Products Advisory Committee met in Silver Spring, Maryland, on March 6 and 22, 2019, to select the influenza viruses for the composition of the influenza vaccine for the 2019-2020 U.S. influenza season.

RheumNow Podcast - I Wanna New Drug (8-30-19)

Dr. Jack Cush vents on choosing new therapies in rheumatoid arthritis.

RheumNow Podcast – Upadacitinib FDA Approved for RA (8.23.19)

Dr. Jack Cush reports on the news and journal reports from the past week on RheumNow.com, including: how your genetics may shape your microbiome; GERD as a risk factor for TMJ?; how can MDA-5+ dermatomyositis be any worse; new drug happenings; StillsNow.com; and more.